By JJ Wilson, Co-Founder, Optimi Health From a global perspective, Canada has always been on the leading edge of healthcare policy. With the introduction of medical assistance in dying laws in 2016 and the legalization of cannabis in 2018, we …
Find the latest news and announcements as well as our press releases and media coverage.
By JJ Wilson, Co-Founder, Optimi Health From a global perspective, Canada has always been on the leading edge of healthcare policy. With the introduction of medical assistance in dying laws in 2016 and the legalization of cannabis in 2018, we …
Yesterday, Optimi Health announced an important MDMA and psilocybin distribution agreement for the psychedelic sector. Our new long-term relationship with Mind Medicine Australia positions Optimi as the primary supplier to Australia’s newly regulated psychedelic market. From day one, our goal …
The announcement follows a national reclassification of MDMA and psilocybin for therapeutic uses in Australia as a result of the years-long effort of Mind Medicine Australia and its dedicated supporters Highlights: • Signed Purchase Orders with Mind Medicine Australia to …
Author: Rowan Dunne, Mugglehead Magazine Vancouver-based Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) has submitted a clinical trial application after successfully producing the first batch of a novel variety of MDMA designated as “OPTI-MHCL.” The company said on …
First-of-its-kind clinical trial establishes the Company’s drug pipeline and strategic plan to supply thousands of therapists Vancouver, British Columbia – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end Canadian-based drug manufacturer and formulator …
The response to our novel #MDMA drug candidate has been overwhelming, so we’ve decided to host a live webinar on February 9th @ 1:00pm EST with CEO Bill Ciprick & CSO Justin Kirkland to tell you more. To access the …
Full end-to-end, GMP manufacturing of OPTI-MHCL solidifies the Company’s plan to address the global demand for MDMA in 2023 and beyond Highlights: Vancouver, British Columbia – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), and …
Expansion to be headlined by Purity Life Health Products, Amazon, and Holt Renfrew VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end Canadian-based drug manufacturer and formulator licensed by Health Canada …
VANCOUVER, BC — January 10, 2023 — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that Mr. Bryan Safarik, Mr. Jacob Safarik, Mr. Jon Schintler, Mr. Dane Stevens, and Mr. JJ …
To Our Valued Shareholders, As 2022 draws to a close, all of us here at Optimi Health are taking a moment to reflect on the accomplishments of the past 12 months as we prepare for an impactful 2023. In that …
Highlights: • $1.85 million in proceeds received through a strategic offering of units at $0.325 per unit with each unit comprised of one common share and one-half of one (1/2) Common Share purchase warrant exercisable at $0.50, for total potential …
Highlights: The safe supply of psychedelic drug products manufactured at a GMP-level is critical in treating serious mental health issues. Minister of Mental Health and Addictions, the Honourable Carolyn Bennett, has publicly stated that safe drug supply is paramount to …
VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP grade psilocybin and other psychedelic substances, most notably MDMA, is pleased …
Magic mushrooms are set to be analyzed, tested and ready for global distribution this fall VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed what …
EU-GMP, operational, and service excellence to drive world-class sales pipeline VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psychedelic …
Company set to introduce psychedelic product catalogue showcasing in-house EU-GMP manufacturing expertise VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce and supply natural, …
Company encouraged by medicinal and therapeutic regulatory developments in Costa Rica VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible …
VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psychedelic and functional mushrooms for transformational human experiences, is pleased to …
VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psychedelic and functional mushrooms for transformational human experiences, has received permission …
A letter from the Health and Human Services Department discloses the anticipated FDA approval of MDMA and psilocybin treatments. In something of a bolt from the blue, Mattha Busby of The Intercept shared the groundbreaking news from Washington D.C. on …
VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (“Optimi” or the “Company”), a homegrown, Canadian company cultivating and synthesizing high quality psychedelics and natural functional and psilocybin mushroom strains for transformational human experiences, is pleased to announce …
Partnership is a unique opportunity to showcase Canada as a clinical and cultivation mecca VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company cultivating and synthesizing high quality psychedelics …
Optimi CEO, Bill Ciprick, recently sat down with Investing News Network’s (INN) Stuart McNish to talk about a host of things all psychedelics and Optimi’s plan to commercialize and supply the next generation of natural psilocybin and synthetic psychedelic medicine. …
VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural, scalable, and accessible psychedelic and functional mushrooms, as well as synthetic formulations for transformational human experiences, is pleased …
Company to maximize world-class EU-GMP operations, potentially opening future revenue-generating opportunities VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi”) or the (“Company”), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational …
Strategic partnership will focus on improving regulatory outcomes in therapist training and safe supply of psilocybin VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural, scalable, and accessible mushroom …
by Lara Goldstein, Benzinga Staff Writer Optimi (OPTHF), the Canadian, home-grown mushroom formulations producer has signed not one but two supply deals with different research companies. The first involves Halucenex Life Sciences Inc. owned by Australian Creso Pharma (CPH). Halucenex’s mission involves researching …
By Taya Fast Global News Magic mushrooms are now growing in Princeton, B.C., as a new mushroom research and development facility opened on Friday. Optimi Health Corp. is a Canadian-based company that grows psilocybin-producing mushrooms and functional mushrooms for clinical trials, drug companies, and …
By Azuka Onwuka Optimi Health Corp (OPTI) has signed a supply agreement with Filament Health, a clinical-stage natural psychedelic drug development company. Filament has engaged Optimi to supply psilocybin mushrooms cultivated in Optimi’s recently inaugurated 20,000 square foot …
Optimi Health set to produce 2,000 kilograms of dried psilocybin mushrooms a month in its Princeton facilities Brady Strachan · CBC News · Posted: May 28, 2022 7:00 AM PT | Last Updated: May 28 B.C.-based company Optimi Health has harvested its …
Collaborative expertise a hallmark for future supply of natural psilocybin VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational …
By Casey Richardson A new cultivation facility that is hoping to change lives with psychedelic mushrooms had their grand opening on Friday in Princeton, after being awarded a dealer’s license in February by Health Canada. Optimi Health Corp. is …
Halucenex to receive recently harvested first batch of psilocybe cubensis VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational …
Company to focus on supply agreements and working directly with Canadians and physicians VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural, scalable, and accessible mushroom …
Vancouver’s Optimi Health harvests first batch of psilocybin mushrooms By Glen Korstrom Optimi Health CEO Bill Ciprick New large psilocybin production facilities have started to pop up in B.C., providing the latest evidence that this nascent business sector is expanding …
By ANDREA DEMEER A new “magic mushroom” facility in Princeton is opening its doors to locals as the psilocybin industry starts to take shape all across British Columbia. The grand opening event on Friday, May 27, is set …
Blunt to speak on the importance of understanding psilocybin’s potential role in mental health, reducing barriers to continued research in psychedelic medicine VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a …
New strains to provide crucial insights in mental health research across the sector VANCOUVER, British Columbia, May 17, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural, scalable, …
Lab’s completion brings Company closer to full commercialization. VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed a planned expansion of the on-site analytical …
“Sets the right tone, right standard, and right policy”: Optimi Health CEO, Bill Ciprick VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”) CEO, Bill Ciprick, issued a statement today in response …
Request to modify quantities of psilocybin and psilocin receives approval from Health Canada. VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that a requested Amendment to its Controlled Substances Dealer’s …
To Our Valued Shareholders, Supporters, Friends and Colleagues: Big things are happening at Optimi. Thank you for being a part of them. As we’ve kicked off our year of commercialization, we’ve experienced an incredible response from backers at every level. …
Company will host in-person and virtual tours for media, investors, and residents on May 27, 2022 VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it will be …
By Amanda Siebert – Mar 22, 2022 Based in Princeton, B.C., Optimi Health (CNSX: OPTI | OTCMKTS: OPTHF | FRA: 8BN) is one of a handful of Health Canada-licensed companies focusing on the production of psilocybin, but there are a few things that set it …
VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has commenced the cultivation of natural GMP-grade psilocybin mushrooms at its Princeton, British Columbia facility. “These mushrooms are …
VANCOUVER, British Columbia, March 08, 2022 — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is …
VANCOUVER, BC (March 1, 2022) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is pleased …
B.C. company brings highest quality fruiting body mushroom formulations to the Canadian nutraceutical market VANCOUVER, BC (February 22, 2022) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand …
VANCOUVER, BC (GLOBE NEWSWIRE – February 16, 2022) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness …
Optimi Health to become a global leader in all-natural psilocybin production VANCOUVER, BC (February 7, 2022) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and …
Company identifies unique two-part extraction and transdermal delivery process VANCOUVER, BC (GLOBE NEWSWIRE – January 18, 2022) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional …
SAP amendment allows practitioners to request access to psychedelic drugs for patients with serious or life-threatening conditions on a case-by-case basis. VANCOUVER, BC ( January 5, 2022) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the …
VANCOUVER, BC (December 21, 2021) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional as well as novel psychedelic compounds focused on the health and wellness …
VANCOUVER, BC (December 7, 2021) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional as well as novel psychedelic compounds focused on the health and wellness …
VANCOUVER, BC (November 3, 2021) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional as well as novel psychedelic compounds focused on the health and wellness …
VANCOUVER, BC (October 19, 2021) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional as well as novel psychedelic compounds focused on the health and wellness …
Company utilizes green chemistry to stabilize natural product with higher yields VANCOUVER, BC (October 5, 2021) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on …
VANCOUVER, BC (GLOBE NEWSWIRE – September 14, 2021) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to …
VANCOUVER, British Columbia, August 31, 2021 — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that …
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC (GLOBE NEWSWIRE – August 18, 2021) – Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically …
VANCOUVER, BC – (August 13, 2021) – Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), announces that it has filed its condensed interim consolidated financial statements and related management discussion and analysis for the period …
VANCOUVER, BC (August 10, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, announced today that preparations for a …
VANCOUVER, BC ( July 27, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), as part of its strategic aim to fully investigate the science of mushrooms, is pleased to announce the engagement of …
VANCOUVER, BC (July 13, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products is pleased to announce its inclusion in the first psychedelics Exchange Traded Fund (“ETF”) …
VANCOUVER, BC (July 7, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products announced today that it has engaged the consulting services of Donohoe Advisory Associates LLC …
VANCOUVER, BC (June 29, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products is pleased to announce it has initiated corporate support as one of TheraPsil’s first …
VANCOUVER, BC (GLOBE NEWSWIRE – June 23, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products today announced that Thomas Finetti, partner at Charney IP Law, has …
VANCOUVER, BC (June 17, 2021) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated mushroom product developer wishes to advise it has successfully concluded uplisting to the OTCQB exchange operated by OTC …
Company Advised by Health Canada to Proceed with Phase 1 Psilocybin Study Application VANCOUVER, BC (GLOBE NEWSWIRE – June 15, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated mushroom product …
VANCOUVER, BC (June 8, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that it …
VANCOUVER, BC (GLOBE NEWSWIRE – June 3, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to …
VANCOUVER, BC – (May 25, 2021) – Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), announces that it has filed its condensed interim consolidated financial statements and related management discussion and analysis for the period …
Company welcomes leadership oversight of new product research, formulations & trials VANCOUVER, BC (GLOBE NEWSWIRE – May 26, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom …
Partnership Aimed at Delivering Psychedelic Capsule for Dosing Study in Human Clinical Trial VANCOUVER, BC (GLOBE NEWSWIRE – May 11, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated …
R&D Program Developing 100% Optimi-Owned Psychedelic Capsule for Human Clinical Trial Dosing Study VANCOUVER, BC (GLOBE NEWSWIRE – May 4, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated …
Awards contracts for interior finishing and technology installation VANCOUVER, BC (GLOBE NEWSWIRE – April 27, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused …
VANCOUVER, BC (GLOBE NEWSWIRE – April 14, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to …
VANCOUVER, BC (GLOBE NEWSWIRE – April 6, 2021) — Optimi Health Corp. (CSE: OPTI) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce the …
Company on-track for Q3 planting with 50-day window to initial harvest VANCOUVER, BC (March 23, 2021) — Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and …
Company Introduces Celebrity Wellness Expert Harley Pasternak as Advisor VANCOUVER, BC (GLOBE NEWSWIRE – March 16, 2021) — Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and …
Commercialization of All-Natural Psychedelics Targeted Through Life Sciences Expertise VANCOUVER, BC (GLOBE NEWSWIRE – March 9, 2021) — Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and …
Agreement propels development of safe and effective proprietary products and formulations for the emerging psychedelic industry VANCOUVER, BC (March 2, 2021) — Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused …
Are You Seeing This? By Nathan Caddell – Feb 25, 2021 Optimi Health Corp. hit the Canadian Stock Exchange today with an oversubscribed $20.7-million initial public offering. The Princeton-based company, founded by a group of high-school friends, hopes to become Canada’s …
NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, February 25, 2021 — Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health …
Vancouver-based company that focuses on health and wellness through pharmaceutical magic mushrooms has completed a $20.7 million initial public offering. Optimi Health Corp is “developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness markets.” …
NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, February 18, 2021— Optimi Health Corp. (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, …
NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, January 15, 2021— Optimi Health Corp. (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, …
[et_pb_section admin_label=”section”] [et_pb_row admin_label=”row”] [et_pb_column type=”4_4″][et_pb_text admin_label=”Text”] NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, — (GLOBE NEWSWIRE – November 2, 2020) – Optimi Health Corp. (“Optimi” or the “Company”) developers of …
Vancouver, British Columbia, September 29, 2020, Optimi Health Corp. (“Optimi” or the “Company”) is pleased to announce that it has closed an oversubscribed non-brokered private placement (the “Private Placement”) of 17,963,005 special warrants (each, a “Special Warrant”) at a price …
Regulator Filings
Legal Counsel: Norton Rose Fulbright
Auditor: Smythe CPA
Transfer Agent: Endeavor Trust
Corporate Visibility & Investor Relations: Kydder Group
Trading Symbol: CSE: OPTI | OTC:OPTHF |
FRA: 8BN
CUSIP Number: 68405H100
ISIN Number: CA68405H1001
WKN: A2QQEL
Issued & Outstanding: (30/06/2022) 80,451,883
Incorporated: BC / May 27, 2020
Year End: September 30th